期刊文献+

局部晚期非小细胞肺癌同期放化疗研究进展 被引量:14

Current status of combined chemo-radiotherapy for locally advanced non-small cell lung cancer
原文传递
导出
摘要 放化综合治疗是局部晚期非小细胞肺癌(NSCLC)的基本治疗策略。近期研究表明同期放化疗在生存率等方面优于序贯治疗,已成为局部晚期NSCLC的标准治疗模式,但是尚无具体放化结合模式指导临床治疗。为了进一步提高治疗疗效,目前临床研究主要集中于以下几个方面:同期放化治疗加入诱导或巩固化疗、同期放化疗中放疗分割方式的改变、同期放化疗中化疗方式及方案的选择、同期放化疗加入分子靶向治疗。 Combination of chemotherapy and radiotherapy is foundational treatment approach for locally advanced non-small cell lung cancer (NSCLC) patients. Concomitant chemo-radiotherapy have been demonstrated to be better than sequential chemoradiotherapy in survival rate, and it is considered as a standard approach in patients with locally advanced NSCLC. However, the chemo-radiotherapy regimens remain uncertain. The main clinical researches aiming at improving the survival rate of locally advanced NSCLC patients are the addition of induction or consolidation, the alteration of radiation fractionation, the alteration of chemo schema and the integration of molecularly targeted therapies combining with concurrent chemo-radiotherapy.
出处 《国际肿瘤学杂志》 CAS 2009年第3期208-211,共4页 Journal of International Oncology
关键词 非小细胞肺 放射疗法 化学疗法 Carcinoma, non-small cell lung Radiotherapy Chemotherapy
  • 相关文献

参考文献17

  • 1Sause W, Kolesar P, Taylor Ⅳ S, et al. Final results of phase Ⅲ trial in regionally advanced unresectable non-small cell lung cancer. Radiation Therapy Oncology, Eastern Cooperative Ontology Group, and Southwest Oncology Group. Chest, 2000, 117(2):358-364.
  • 2Belderbos J, Uitterhoeve L, van Zandwijk N, et al. EORTC LCG and RT Group. Randomised trial of sequential versus concurrent chemoradiotherapy in patients with inoperable non-small cell lung cancer ( EORTC 08972-22973). Eur J Cancer, 2007, 43 ( 1 ) : 114-121.
  • 3Naito Y, Kubota K, Nihei K, et al. Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage Ⅲ non-small cell lung cancer. J Thorac Oncol, 2008, 3 (6) :617-622.
  • 4王卫华,包勇,陈明,李凯新,张力,徐光川.三维适形放疗联合诱导化疗和紫杉醇同期化疗不能手术Ⅲ期非小细胞肺癌的疗效分析[J].中华放射肿瘤学杂志,2008,17(4):252-256. 被引量:10
  • 5Hirsh V, Soulieres D, Duclos M, et al. Phase Ⅱ muhicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage Ⅲ A and Ⅲ B non-small cell lung cancer. J Thorac Oncol, 2007, 2(10) :927-932.
  • 6Vokes EE, Herndon JE, Crawford J, et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage Ⅲ non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol, 2007, 25 (13) :1698-1704.
  • 7Choong NW, Vokes EE, Haraf DJ et al. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage Ⅲ non-small cell lung cancer. J Thorac Oncol, 2008, 3( 1 ) :59-67.
  • 8Huang EH, Liao Z, Gox TM, et al. Comparison of outcomes for patients with unresectable, Locally advanced non-small-cell lung cancer treated with Induction chemotherapy followed by concurrent Chemoradiation vs. Concurrent chemoradiation alone. Int J Radiat Oncol Biol Phys, 2007, 68(3) :779-785.
  • 9Gandara D, Chansky K, Albain KS, et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage Ⅲ B non-smallcell lung cancer: phase-Ⅱ Southwest Oncology Group Study S9504. J Clin Oncol, 2003, 21 (10) :2004-2010.
  • 10Rusu P, Ciuleanu TE, Cernea D, et al. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage Ⅲ non-small cell lung cancer: preliminary results of a phase Ⅱ tudy. J BUON, 2007, 12 ( 1 ) :33-39.

二级参考文献27

  • 1陈明,陈媛媛,冼超贵,刘国贞,吴少雄,崔念基.诱导化疗加后程加速超分割放疗局部晚期非小细胞肺癌临床Ⅰ+Ⅱ期试验结果[J].中华放射肿瘤学杂志,2005,14(4):249-252. 被引量:9
  • 2任宝志,刘孝伟,韩磊,朱培军,孔凡华,山长平.临床Ⅱ期肺鳞癌的后程加速超分割三维适形放疗[J].中华放射肿瘤学杂志,2005,14(6):501-502. 被引量:3
  • 3林贵山,程惠华,傅志超,李东石.晚期非小细胞肺癌同步放化疗的疗效分析[J].中华放射肿瘤学杂志,2006,15(6):462-466. 被引量:21
  • 4Cox JD, Stetz J, Pajak TF. Toxcity criteria of the Radiation Therapy Oncology Group(RTOG) and the European Organization for Research and Treatment of Cancer ( EORTC ). Int J Radiat Oncol Biol Phys, 1995,31:1341-1346.
  • 5Non-small cell lung cancer collaborative group. Chemotherapy in non-small cell lung cancer. Meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J, 1995,311:899-909
  • 6Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced non-small-cell lung cancer. A meta-analysis. Ann Intern Med, 1996,125:723-729.
  • 7Furuse K, Fukuoka M,Kawahara M, et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin,vindesine,and cisplatin in unresectable stage Ⅲ nonsmall-cell lung cancer. J Clin Oncol, 1999,17 : 2692-2699.
  • 8Curran WJ, Scott CB, Langer JL, et al. Long-term benefit is observed in a phase Ⅲ comparison of sequential vs. concurrent chemoradiation therapy for patients with unresectable stage Ⅲ NSCLC. Proc Am Soc Clin Oncol,2003,22: 621.
  • 9Vokes EE, Hemdon JE, Kelley MJ,et al. Induction chemotherapy followed by concomitant chemoradiotherapy(CT/XRT) versus CT/ XRT alone for regionally advanced unresectable non-small cell lung cancer(NSCLC) : initial analysis of a randomized phase Ⅲ trial. Proc Am Soc Clin Oncol,2004,22: 7005.
  • 10Belani CP,Choy H,Bonomi P,et al. Combined chemoradiotherapy regimens ofpaclitaxel and carboplatin for locally advanced nonsmall-cell lung cancer: arandomized phase Ⅱ locally advanced multi-modality protocol. J Clin Oncol,2005,23:5883-5891.

共引文献15

同被引文献86

引证文献14

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部